Texas Medical Center Innovation Institute kicks off third accelerator program

More than 11 medical device startups will head to Texas for the third installment of TMCx, an accelerator program that helps startups partner with industry experts that can help turn entrepreneur’s device concepts into reality.

The Texas Medical Center Innovation Institute is a 15-week program in Houston that lets startups collaborate with top industry and business experts, physicians and scientists, and stakeholders.

Startups attending the program this year include Bloom Labs, a New York-based company that creates credit-card sized rescue inhalers, San Francisco-based Blumio, which creates a sensor to measure blood pressure continuously, and WeaRobot, a Mexico-based company that has developed a concept for an active exoskeleton for seniors and the physically impaired. For a complete list of startups attending the program, click here.

"Very few accelerators have a robust program devoted to medical device startups, so we are filling a huge gap in the life sciences ecosystem," said Erik Halvorsen, PhD, director of the TMC Innovation Institute, in a statement. "Now we are the only accelerator in the country that runs alternating curriculum tracks on med devices and digital health, which will bolster our efforts to attract top talent in health care innovation."

The startups will be guided through areas like intellectual property, product development, regulatory strategies, health policy, marketing, fundraising, contract negotiations and communications. The program runs through November, at which point the companies will make a final pitch to advisors, hospital stakeholders and investors.

Applications for next year’s program will begin being accepted Aug. 17.

 

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Trimed Popup
Trimed Popup